Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units.
about
Stem cell transplantation therapy in Parkinson's diseaseAlternative Donor Transplantation for Acute Myeloid LeukemiaUmbilical cord blood transplantation for the treatment of hematologic malignanciesAdvances in umbilical cord blood manipulation-from niche to bedsideComplement fragment 3a priming of umbilical cord blood progenitors: safety profile.Hyperbaric oxygen improves engraftment of ex-vivo expanded and gene transduced human CD34⁺ cells in a murine model of umbilical cord blood transplantation.Haploidentical vs cord blood transplantation for adults with acute myelogenous leukemia.Umbilical cord blood transplantation: the first 25 years and beyond.Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants.Umbilical cord blood transplantation supplemented with the infusion of mesenchymal stem cell for an adolescent patient with severe aplastic anemia: a case report and review of literatureEnhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function.Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells).A soluble granulocyte colony stimulating factor decoy receptor as a novel tool to increase hematopoietic cell homing and reconstitution in mice.Factors predicting single-unit predominance after double umbilical cord blood transplantation.Background and future considerations for human cord blood hematopoietic cell transplantation, including economic concerns.Future of cord blood for oncology uses.Going straight to the point: intra-BM injection of hematopoietic progenitors.Double umbilical cord blood transplant: more than a cell dose?Clinical utilization of cord blood over human health: experience of stem cell transplantation and cell therapy using cord blood in Korea.Cord blood stem cells for hematopoietic transplantation.An overview of the progress on double umbilical cord blood transplantation.Cellular therapies supplement: strategies for improving transplant efficiency in the context of cellular therapeutics.Molecular mechanisms underlying adhesion and migration of hematopoietic stem cells.Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: what should we choose when no HLA-matched related donor is available?Stem cell bioengineering strategies to widen the therapeutic applications of haematopoietic stem/progenitor cells from umbilical cord blood.Cord Blood Transplantation: Can We Make it Better?Advances in umbilical cord blood cell therapy: the present and the future.Phase II study of intrabone single unit cord blood transplantation for hematological malignanciesA phase I/II trial of intrabone marrow cord blood transplantation and comparison of the hematological recovery with the Japanese nationwide database.Optimization of intrabone delivery of hematopoietic progenitor cells in a swine model using cell radiolabeling with [89]zirconium.Double cord blood transplantation: co-operation or competition?Direct bone marrow HSC transplantation enhances local engraftment at the expense of systemic engraftment in NSG mice.Indiscernible Benefit of Double-Unit Umbilical Cord Blood Transplantation in Children: A Single-Center Experience From Hong Kong.Overcoming the barriers to umbilical cord blood transplantation.A prospective multicenter phase II study of intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning.Comparative in vitro analysis of different hematopoietic cell populations from human cord blood: in search of the best option for clinically oriented ex vivo cell expansion.Going home for the holidays? Take a shortcut!Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study.Functional Integrity and Gene Expression Profiles of Human Cord Blood-Derived Hematopoietic Stem and Progenitor Cells Generated In Vitro.Evaluation of hematopoietic stem cell expansion in the presence of garcinol
P2860
Q26778682-A3DDC278-661E-474F-AF54-FD4807EA0A55Q26799456-466F2316-031E-4DF6-92AF-C64318FAA763Q26820829-71BBF1D0-92E2-4B74-9357-896E58C81F85Q26824305-A88A8D04-A2BD-47C3-913E-8721F4D02F53Q30366297-3B28F32B-0F7F-437D-BD6F-E350BBB90891Q33821459-2475E1A1-F8A4-451F-9B49-5094086752A8Q34232835-C748F993-CC27-4549-AA21-CEDCD423F33EQ34344669-5D2A8484-C842-43E5-8E15-F525F683F108Q34440672-55F81CF9-D559-4CC0-AE1A-F3A7EC0272B4Q35746929-2A058B94-EB4E-4055-BD20-463696C2F0B5Q36192813-F7966C91-19D8-4F07-BFF8-B90CF276DE2DQ36288646-B53C7E71-A7E4-4381-AD80-4D1DE5140473Q36648047-35A9B2B5-6DB5-4113-A319-544C91F8C77FQ36664471-8520FA19-ADE1-4040-B44B-63B0D3E6FB69Q37443125-50ABF903-4FE0-4EC2-9AEA-CBEA11D1D5AEQ37607977-918163DD-5946-4980-92DF-AAC69F3ACEA2Q37715706-9191ED88-FEBB-45FA-B221-9DE4B54968E7Q37724186-B55E8BAA-79DF-4F80-AEFD-22DC25630A37Q37725142-A475056A-5A0C-4009-BBD0-C788842B674EQ37784455-62E101D8-7AA7-449A-86B1-6E910C1B3D75Q37872506-A649D060-3118-4A76-A606-DF54EB117D85Q37954790-7316AD79-72F0-4A82-832A-EDC2954A2719Q38014665-EBCD703C-CD35-4738-8D34-316F5D4CF0FBQ38087853-2BD148B1-A4B3-4D97-A2B8-FF38CE7F27C5Q38097003-3144636D-2487-494E-B0FA-B08A62DEBB30Q38142167-113959A9-367D-41F0-89E6-DB2EEFFEC757Q38734758-FF5621EA-1D68-446B-9B66-73AD24990A21Q38743140-981B5E16-DA36-479F-A03C-3666ACC40BB2Q39031937-2F157FFD-6C19-4558-9F5F-88EDFC1A4215Q39042577-FB428725-FA18-4931-9AC6-61818A6A671DQ39805764-1B7EA2E8-BBA5-4C83-8937-091BB68CBBA0Q40025549-9B264646-0F6C-4654-BACA-A2F88CF5F5C8Q40472138-6ADD3D36-9367-4080-9197-EF6A82FB8E0DQ42974699-168EB1F5-8391-4156-88A4-C597D9F00EA8Q47228036-E27EC66D-82E5-47FA-BB56-773D7050548DQ47326106-1D747B41-F0AA-41D8-A2BE-D2DECA35AC42Q48324190-EBEDC6A7-56FD-4C6D-A525-65A2A33093B8Q50531641-2D09AFA1-A23C-49AF-ACE8-642D64EB40A4Q53281888-1EBEF226-3D00-420B-A090-36A887FB8C93Q58130720-A6EDD65A-DEB8-4039-9637-D6101523FFF2
P2860
Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intra-BM injection to enhance ...... o partially HLA-matched units.
@en
Intra-BM injection to enhance ...... o partially HLA-matched units.
@nl
type
label
Intra-BM injection to enhance ...... o partially HLA-matched units.
@en
Intra-BM injection to enhance ...... o partially HLA-matched units.
@nl
prefLabel
Intra-BM injection to enhance ...... o partially HLA-matched units.
@en
Intra-BM injection to enhance ...... o partially HLA-matched units.
@nl
P2093
P2860
P356
P1476
Intra-BM injection to enhance ...... wo partially HLA-matched units
@en
P2093
C G Brunstein
D J Weisdorf
J E Wagner
J N Barker
P B McGlave
P2860
P2888
P304
P356
10.1038/BMT.2008.417
P407
P577
2009-01-12T00:00:00Z